Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

SVA

Sinovac Biotech (SVA)

Sinovac Biotech Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SVA
DateHeureSourceTitreSymboleSociété
29/04/202423h53Business WireSINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-FNASDAQ:SVASinovac Biotech Ltd
21/02/202412h09Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]NASDAQ:SVASinovac Biotech Ltd
21/02/202412h02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SVASinovac Biotech Ltd
21/02/202408h56Business WireSinovac Amends Shareholder Rights PlanNASDAQ:SVASinovac Biotech Ltd
02/02/202417h19Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:SVASinovac Biotech Ltd
19/01/202412h58Business Wireシノバック取締役会、一方的な部分公開買い付けを全会一致で退けるNASDAQ:SVASinovac Biotech Ltd
18/01/202420h54Business WireSinovac董事會一致反對Alternative Liquidity主動提出的部分公開收購方案NASDAQ:SVASinovac Biotech Ltd
18/01/202420h47Business WireLe conseil d'administration de Sinovac rejette à l'unanimité une offre partielle non sollicitéeNASDAQ:SVASinovac Biotech Ltd
18/01/202419h33Business WireDas Board of Directors von Sinovac lehnt einstimmig ein unaufgefordert abgegebenes Teilkaufangebot abNASDAQ:SVASinovac Biotech Ltd
18/01/202413h13Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:SVASinovac Biotech Ltd
18/01/202413h00Business WireSinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender OfferNASDAQ:SVASinovac Biotech Ltd
08/01/202422h46Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:SVASinovac Biotech Ltd
04/12/202312h01Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SVASinovac Biotech Ltd
12/09/202312h10Business Wireシノバック、新型コロナウイルスに対するSA55抗体注射剤の臨床試験について進展を報告NASDAQ:SVASinovac Biotech Ltd
11/09/202316h36Business WireSINOVAC rend compte des progrès réalisés dans le cadre de son essai clinique concernant l’injection anti-COVID-19 à base d’anticorps SA55NASDAQ:SVASinovac Biotech Ltd
11/09/202316h36Business WireSINOVAC informiert über die Fortschritte bei der klinischen Studie für den Anti-COVID-19-Antikörper SA55 InjectionNASDAQ:SVASinovac Biotech Ltd
11/09/202311h55Business WireSINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 InjectionNASDAQ:SVASinovac Biotech Ltd
06/09/202313h35Business Wireシノバック取締役会、同意なき株式の部分公開買付を全会一致で拒否NASDAQ:SVASinovac Biotech Ltd
05/09/202318h16Business WireSinovac-Vorstand lehnt ein unangefordertes Teilübernahmeangebot einstimmig abNASDAQ:SVASinovac Biotech Ltd
05/09/202317h36Business WireLe conseil d’administration de Sinovac rejette à l’unanimité une offre publique d’achat partielle non sollicitéeNASDAQ:SVASinovac Biotech Ltd
29/08/202319h08Business Wireシノバック、部分的な株式公開買付を一方的に受けたことを確認NASDAQ:SVASinovac Biotech Ltd
29/08/202315h04Business WireSinovac bestätigt den Erhalt eines unangeforderten TeilübernahmeangebotsNASDAQ:SVASinovac Biotech Ltd
29/08/202312h05Business WireSinovac confirme la réception d'une offre publique d’achat partielle non sollicitéeNASDAQ:SVASinovac Biotech Ltd
29/08/202309h07Business WireSinovac Confirms Receipt of an Unsolicited Partial Tender OfferNASDAQ:SVASinovac Biotech Ltd
28/08/202321h40Business Wireシノバック、子会社の法定代理人変更を発表NASDAQ:SVASinovac Biotech Ltd
28/08/202319h19Business WireSinovac meldet Wechsel des rechtlichen Vertreters von Sinovac BeijingNASDAQ:SVASinovac Biotech Ltd
28/08/202317h57Business WireSinovac annonce un changement au niveau du représentant légal de Sinovac PékinNASDAQ:SVASinovac Biotech Ltd
28/08/202313h44Business WireSinovac Announces Change of Legal Representative of Sinovac BeijingNASDAQ:SVASinovac Biotech Ltd
15/08/202312h00Business WireSINOVAC Reports Unaudited First Half of 2023 Financial ResultsNASDAQ:SVASinovac Biotech Ltd
25/05/202313h14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SVASinovac Biotech Ltd
 Showing the most relevant articles for your search:NASDAQ:SVA

Dernières Valeurs Consultées